Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

被引：0
|
作者：
Hisaharu Shikata
Yoshihiro Yakushijin
Jun Yamanouchi
Taichi Azuma
Masaki Yasukawa
机构：
[1] Ehime University Graduate School of Medicine,Department of Bioregulatory Medicine, Ehime University Hospital
[2] Ehime University Graduate School of Medicine,Cancer Center, Ehime University Hospital
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Hematological nadir; Febrile neutropenia (FN); G-CSF prophylaxis; R-CHOP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 50 条
  • [1] Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP
    Shikata, Hisaharu
    Yakushijin, Yoshihiro
    Yamanouchi, Jun
    Azuma, Taichi
    Yasukawa, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 178 - 185
  • [2] USE OF R-CHOP REGIMEN IN PATIENTS WITH B-CELL VIRUS ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL)
    Imamov, A.
    Abdiganieva, R.
    Pulatov, A.
    Abdurahmonov, A.
    Ibragimov, M.
    Tuydzhanova, K. H.
    Khakimov, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 43 - 43
  • [3] Primary Bone Marrow B-cell Non-Hodgkin's Lymphoma Successfully Treated with R-CHOP
    Qian, Liren
    Zhang, Zhi
    Shen, Jianliang
    Liu, Yi
    WEST INDIAN MEDICAL JOURNAL, 2013, 62 (01): : 89 - 91
  • [4] Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
    Kim, Do Young
    Nam, Jehyun
    Chung, Joo-Seop
    Jeon, Byeol Eun
    Lee, Ji Hyun
    Jo, Jae-Cheol
    Kim, Sang-Woo
    Shin, Ho-Jin
    CANCER RESEARCH AND TREATMENT, 2022, 54 (04): : 1256 - 1267
  • [5] Prophylactic pegfilgrastim is safe and effective for chemotherapy-induced neutropenia in patients with Hodgkin disease and non-Hodgkin lymphoma
    Gregory, S
    Grigg, A
    Moore, T
    PROCEEDINGS OF THE XVII MEETING INTERNATIONAL SOCIETY OF HAEMATOLOGY (EUROPEAN AND AFRICAN DIVISION), 2003, : 231 - 237
  • [6] RISK OF FEBRILE NEUTROPENIA AND USE OF G-CSF PRIMARY PROPHYLAXIS IN NON-HODGKIN'S LYMPHOMA PATIENTS RECEIVING R-CHOP-21
    Haioun, C.
    Jaeger, U.
    Lugtenburg, P.
    Pettengell, R.
    Principe, F.
    Rossi, F.
    Salar, A.
    Schwenkglenks, M.
    Verhoef, G.
    Edmundson, S.
    Bacon, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 105 - 105
  • [7] Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan
    Yokoyama, Masahiro
    Kusano, Yoshiharu
    Takahashi, Anna
    Inoue, Norihito
    Ueda, Kyoko
    Nishimura, Noriko
    Mishima, Yuko
    Terui, Yasuhito
    Nukada, Tomoyuki
    Nomura, Takanobu
    Hatake, Kiyohiko
    SUPPORTIVE CARE IN CANCER, 2017, 25 (11) : 3313 - 3320
  • [8] Incidence and risk factors of febrile neutropenia in patients with non-Hodgkin B-cell lymphoma receiving R-CHOP in a single center in Japan
    Masahiro Yokoyama
    Yoshiharu Kusano
    Anna Takahashi
    Norihito Inoue
    Kyoko Ueda
    Noriko Nishimura
    Yuko Mishima
    Yasuhito Terui
    Tomoyuki Nukada
    Takanobu Nomura
    Kiyohiko Hatake
    Supportive Care in Cancer, 2017, 25 : 3313 - 3320
  • [9] A Randomized Controlled Clinical Study of Peg-Rhg-CSF for Preventing Chemotherapy-Induced Neutropenia in Patients with B-Cell Non-Hodgkin Lymphoma
    Zhen, Changqing
    Ding, Mei
    Lu, Kang
    Ge, Xueling
    Chen, Na
    Fang, Xiaosheng
    Sui, Xiaohui
    Jiang Yujie
    Liu, Xin
    Li, Ying
    Wang, Xianghua
    Li, Ying
    Zhang, Lingyan
    Xu, Hongzhi
    Fan, Juan
    Wang, Xin
    BLOOD, 2019, 134
  • [10] The effect of G-CSF after chemotherapy with CHOP in patients with non-Hodgkin's lymphoma and HIV infection
    Navarro, JT
    Ribera, JM
    GomezEspuch, J
    Feliu, E
    MEDICINA CLINICA, 1996, 107 (03): : 118 - 119
12345